Question

Difficulty: HardPulmonary and Critical Care

A patient presents to the emergency department with a 33-day history of worsening dyspnea and increased production of purulent, yellow sputum. The patient is 7272 years of age and has documented heart failure with preserved ejection fraction, as well as advanced chronic obstructive pulmonary disease (COPD). His home medications consist of umeclidinium, fluticasone, and lisinopril.

Upon evaluation, he is using accessory muscles to breathe. Vital signs show a temperature of 37.2∘37.2^\circ C (99.0∘99.0^\circ F), a blood pressure of 145/90145/90 mm Hg, a heart rate of 112112/min, and a respiratory rate of 2626/min. Pulse oximetry displays 88%88\% on ambient air. Physical examination reveals jugular venous distention up to 88 cm above the sternal angle. Auscultation of the lungs demonstrates a prolonged expiratory phase with diffuse wheezing and scattered basilar crackles. The patient has trace bilateral pitting edema in the lower extremities.

A Gram stain of the sputum demonstrates numerous polymorphonuclear leukocytes and Gram-positive diplococci.

An arterial blood gas analysis obtained on room air indicates:

ParameterValue
pH7.287.28
PaCO2_26464 mm Hg
PaO2_25656 mm Hg
HCO3−_3^-2929 mEq/L

A chest radiograph displays hyperinflation and flattened hemidiaphragms but lacks focal consolidations or pleural effusions.

Which of the following represents the most appropriate initial management for this patient?

  1. Noninvasive positive pressure ventilation, nebulized bronchodilators, systemic glucocorticoids, and azithromycinAnswer
  2. B
    Endotracheal intubation, invasive mechanical ventilation, and diuresis with furosemide
  3. C
    Noninvasive positive pressure ventilation, nebulized bronchodilators, systemic glucocorticoids, and piperacillin-tazobactam
  4. D
    Nasal cannula oxygen therapy, nebulized bronchodilators, systemic glucocorticoids, and acetazolamide
  5. E
    High-flow nasal cannula oxygen therapy, intravenous furosemide, and sublingual nitroglycerin

Answer

The most appropriate initial management is to start noninvasive positive pressure ventilation (NIPPV), nebulized bronchodilators, systemic glucocorticoids, and an antibiotic such as azithromycin.
The correct management consists of noninvasive positive pressure ventilation (NIPPV), bronchodilators, systemic glucocorticoids, and azithromycin. This patient is experiencing a severe COPD exacerbation, evidenced by the three cardinal symptoms: increased dyspnea, increased sputum volume, and purulent sputum. The arterial blood gas demonstrates acute-on-chronic respiratory acidosis with a pH of 7.28. NIPPV is strongly indicated as first-line therapy for COPD exacerbations when the pH is between 7.20 and 7.30. It significantly reduces mortality and the need for endotracheal intubation. The sputum Gram stain reveals Gram-positive diplococci, which is characteristic of Streptococcus pneumoniae. Therefore, azithromycin provides excellent, targeted coverage for the most likely pathogen.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the presentation.
The patient has a COPD exacerbation, indicated by increased dyspnea, increased sputum volume, and purulent sputum. The JVD and trace edema are likely due to chronic cor pulmonale, not acute left heart failure, supported by the hyperinflated lungs on chest radiograph.
Accurate diagnosis is required to select the correct treatment pathway and avoid inappropriate therapies like aggressive diuresis.
2
Analyze the arterial blood gas (ABG) to determine the severity of respiratory failure.
The ABG shows an acute-on-chronic respiratory acidosis. The pH is 7.28 (acidemia), PaCO2 is 64 mm Hg (hypercapnia), and HCO3- is 29 mEq/L (chronic metabolic compensation).
The degree of acidemia dictates the level of ventilatory support needed.
3
Determine the appropriate ventilatory support based on the ABG.
NIPPV is the first-line intervention for COPD exacerbations with acute respiratory acidosis characterized by a pH between 7.20 and 7.30.
NIPPV reduces the work of breathing, improves gas exchange, and significantly decreases the need for invasive intubation and mortality in this specific patient population.
4
Select the appropriate pharmacologic adjuncts including antibiotics based on the Gram stain.
Systemic glucocorticoids and nebulized bronchodilators are standard. The Gram stain shows Gram-positive diplococci (Streptococcus pneumoniae). Therefore, a macrolide (like azithromycin) or ceftriaxone is indicated, rather than broad-spectrum anti-pseudomonal agents.
Antibiotic stewardship principles require targeting the likely pathogen to prevent resistance and minimize side effects.

Key Concept

In patients with a severe COPD exacerbation complicated by acute respiratory acidosis (pH 7.20-7.30), noninvasive positive pressure ventilation (NIPPV) is the first-line ventilatory support, and empiric antibiotics should be targeted based on clinical risk factors and Gram stain when available.
Estimated Time:2m 30s
Rate this question